Colon Cancer Home > Urbitux

Were you looking for information on Erbitux? Urbitux is a common misspelling of Erbitux.
People who have advanced colorectal carcinoma or squamous cell carcinoma affecting the head and neck may be given Erbitux® (cetuximab) as part of their treatment plan. The dose your healthcare provider recommends will depend on various factors, including how you respond to it and the condition that is being treated. These factors can also affect how long treatment lasts. Erbitux is administered as a weekly injection.
(Click Erbitux to learn more, including how this medicine works, possible side effects, and possible drug interactions. You can also click any of the links in the box to the right for specific information.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.